Cardiac G protein-coupled receptors that couple to G␣ s and stimulate cAMP formation (eg, ␤-adrenergic, histamine, serotonin, and glucagon receptors) play a key role in cardiac inotropy. Recent studies in rodent cardiac myocytes and transfected cells have revealed that one of these receptors, the ␤ 2 -adrenergic receptor (AR), also couples to the inhibitory G protein G␣ i (activation of which inhibits cAMP formation). If ␤ 2 ARs could be shown to couple to G␣ i in the human heart, it would have important ramifications, because levels of G␣ i increase with age and in failing human heart. Therefore, we investigated whether ␤ 2 ARs in the human heart activate G␣ i . By photoaffinity labeling human atrial membranes with [ 32 P]azidoanilido-GTP, followed by immunoprecipitation with antibodies specific for G␣ i , we found that G␣ i is activated by stimulation of ␤ 2 ARs but not of ␤ 1 ARs. In addition, we found that other G␣ s -coupled receptors also couple to G␣ i , including histamine, serotonin, and glucagon. When coupling of these receptors to G␣ i is disrupted by pertussis toxin, their ability to stimulate adenylyl cyclase is enhanced. These data provide the first evidence that ␤ 2 AR and many other G␣ s -coupled receptors in human atrium also couple to G␣ i and that abolishing the coupling of these receptors to G␣ i increases the receptor-mediated adenylyl cyclase activity. (Circ Res. 2000;87:705-709.) 
B eta-adrenergic receptors (␤ARs), which couple to G␣ s and stimulate adenylyl cyclase (AC) activity, play a key role in cardiac function. 1 An important recent finding in ␤AR signaling is that the rodent cardiac ␤ 2 AR couples to both stimulatory (G␣ s ) and inhibitory (G␣ i ) G proteins, [2] [3] [4] as does the recombinant ␤ 2 AR transiently expressed in HEK293 cells. 5 The activation of G␣ i by ␤ 2 ARs may have important clinical implications because cardiac G␣ i levels increase in failing heart 6 -8 and in aging. 9 This increase in cardiac G␣ i could increase the number of ␤ 2 ARs that are coupled to G␣ i , resulting in a decrease in cardiac ␤AR function seen in older people and in patients with congestive heart failure. However, signaling through cardiac ␤ 2 ARs exhibits considerable diversity among mammalian species (for review, see Xiao et al 10 ) . Therefore, before we implicate the coupling of ␤ 2 AR to G␣ i as a factor in this observed reduction in cardiac ␤AR function, ␤ 2 ARs must first be shown to couple to G␣ i in the human heart as they do in rodents.
The present study sought to determine whether human cardiac ␤ 2 ARs activate G␣ i . Using photoaffinity labeling with [ 32 P]azidoanilido-GTP ([ 32 P]AAGTP) followed by immuno-precipitation with antibodies specific for G␣ s and G␣ i , we show that stimulation of ␤ARs in human atrial membranes with isoproterenol leads to the activation of both G␣ s and G␣ i . Whereas both ␤ 1 ARs and ␤ 2 ARs activate G␣ s , only ␤ 2 ARs activate G␣ i . Interestingly, cardiac G␣ i is also activated by stimulation of several other G␣ s -coupled receptors including histamine, serotonin, and glucagon. When the coupling of these receptors to G␣ i is disrupted by pertussis toxin (PTX), their ability to stimulate AC is enhanced. These data provide the first evidence that ␤ 2 ARs and several other G␣ s -coupled cardiac G protein-coupled receptors (GPCRs) in human atrium couple to both G␣ s and G␣ i .
Materials and Methods

Human Atrial Samples
Human atrial samples were obtained under an Institutional Review Board-approved protocol from 25 patients age 51 to 67 years (mean 57.8Ϯ4.9 years) undergoing cardiac surgery involving cardiopulmonary bypass at Duke University Medical Center. A piece of right atrial appendage weighing 60 to 150 mg was obtained at the time of atrial cannulation, frozen immediately in liquid nitrogen, and stored at Ϫ80°C. Eleven atrial samples were used solely for photoaffinity labeling experiments, 12 were used solely for AC experiments, and 2 were used for both types of experiments. Ten of the 13 samples used for photoaffinity labeling, and 11 of the 14 samples used for AC assays were taken from patients taking ␤AR antagonists. There was no discernible difference in results between patients who received ␤AR antagonists and those who did not.
Atrial Membrane Preparation
Atrial samples were homogenized and centrifuged. The membrane pellets were resuspended at 2 to 4 mg protein/mL in either buffer A (containing [in mmol/L] HEPES [pH 7.4] 50, EDTA 1, NaCl 50, and benzamidine 2) for photoaffinity labeling assays or buffer B (containing [in mmol/L] Tris [pH 7.4] 75, MgCl 2 12.5, EDTA 2, and benzamidine 1, and [in mg/L] soybean trypsin inhibitor 10, leupeptin 10, and aprotinin 5) for AC assays.
Photoaffinity Labeling With [ 32 P]AAGTP and Immunoprecipitation
[ 32 P]AAGTP was synthesized according to published procedures and purified by thin-layer chromatography on polyethylenimine cellulose (J.T. Baker). 11, 12 Photoaffinity labeling of human atrial membranes (85 g protein) was performed using 2 Ci of [ 32 P]AAGTP in a total volume of 60 L in the presence of various drugs indicated in the figure legends. Immunoprecipitation of photolabeled G␣ subunits and subsequent analysis by SDS-PAGE/ autoradiography was performed as described previously. 11, 12 
PTX Treatment of Atrial Membranes and AC Assays
PTX (50 ng/L) was activated by incubation with 100 mmol/L DTT and 0.25% SDS for 30 minutes at 30°C as described previously, 13 with minor modifications, and mixed with atrial membranes. A second tube containing the same volumes of all constituents, with the exception of H 2 O in place of PTX, was treated in the same fashion and used as a control. AC activity was measured according to the method of Salomon et al 14 and Johnson and Salomon 15 as described previously, 16 with the addition of 0.4 mmol/L 3-isobutylmethylxanthine to the reaction mixture.
Statistical Analysis
Results are presented as meanϮSD. Because of the large variations in basal activities between patients, the data are reported as percentage change. The statistical significance of agonist stimulation on the incorporation of [ 32 P]AAGTP into G proteins and agonist stimulation of AC were determined by paired t tests on the percentage change from basal. A paired t test was also used to compare AC activities in the control membranes and PTX-treated membranes. To compare the PTX-induced increase in basal, forskolin-stimulated, and ␤ 1 ARstimulated AC activities with the PTX-induced increase in AC stimulation of receptors that couple to both G␣ s and G␣ i , a repeatedmeasures mixed-effects general linear regression model was used. 17, 18 PϽ0.05 was considered significant for all comparisons.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
␤ 2 ARs, but Not ␤ 1 ARs, Stimulate Both G␣ s and G␣ i in Human Atrial Membranes
As shown in Figure 1 , stimulation of human atrial ␤ARs with isoproterenol activates G␣ s (both the long and short isoforms) 19 and G␣ i ; this is revealed by increased photoaffinity labeling of these G␣ subunits with [ 32 P]AAGTP. On average, isoproterenol significantly increased the incorporation of [ 32 P]AAGTP, to 209Ϯ48% of control in G␣ s and to 212Ϯ33% of control in G␣ i . This increase in photoaffinity labeling of both G␣ s and G␣ i is blocked in the presence of the ␤ 2 AR antagonist ICI 118,551, indicating that activation of G␣ s and G␣ i is mediated through ␤ 2 ARs. Importantly, the extent of G␣ i activation by isoproterenol in these membranes is similar to that seen after stimulation of prototypical G i -coupled muscarinic receptors with carbachol (data not shown).
In rodent hearts, ␤ 2 ARs, but not ␤ 1 ARs, activate G␣ i . [2] [3] [4] To determine whether this is also the case in human heart, we used the following 2 approaches: (1) we stimulated ␤ARs with agonists selective for either ␤ 1 ARs or ␤ 2 ARs and (2) we stimulated ␤ARs with the nonselective agonist isoproterenol in the presence of a ␤ 1 AR-or ␤ 2 AR-selective antagonist (Figures 2 and 3 , respectively). As shown in Figure 2 , whereas both zinterol (agonist for ␤ 2 ARs) and dobutamine (agonist for ␤ 1 ARs) stimulate G␣ s (to 195Ϯ38% and 165Ϯ26% of control, respectively), only zinterol stimulates G␣ i (to 204Ϯ19% of control). Similar results are obtained using ␤ 1 /␤ 2 -selective antagonists; Figure 3 shows that stimulation of G␣ i by isoproterenol is blocked in the presence of ␤ 2 AR-selective antagonist ICI 118,551 but not in the presence of ␤ 1 AR-selective antagonist CGP 20712A. Taken together, these data establish that ␤ 2 ARs, but not ␤ 1 ARs, in human atrial membranes activate G␣ i . Figure 1 . Activation of both G␣ s and G␣ i by ␤ARs in human heart. Human atrial membranes were photoaffinity labeled with [ 32 P]AAGTP in the presence of no drug (Basal), isoproterenol (Iso), or isoproterenol and ICI 118,551 (ICI), each drug at 100 mol/L, as described in Materials and Methods. The photolabeled membranes were immunoprecipitated with either RM/1 antibody (for G␣ s ) or AS/7 antibody (for G␣ i ), and immunoprecipitates were subjected to SDS-PAGE followed by autoradiography. G␣ s -L and G␣ s -S indicate the long and short isoforms of G␣ s , respectively. A representative autoradiogram is shown; the experiment was repeated 4 times with similar results. Figure 2 . ␤ 2 AR, but not ␤ 1 AR, couples to G␣ i . Human atrial membranes were photoaffinity labeled with [ 32 P]AAGTP in the presence of no drug (Basal), 100 mol/L dobutamine (Dobut, ␤ 1 AR agonist), or 100 mol/L zinterol (Zint, ␤ 2 AR agonist) as described in Materials and Methods. Photolabeled membranes were immunoprecipitated with either RM/1 antibody (for G␣ s ) or AS/7 antibody (for G␣ i ), and immunoprecipitates were subjected to SDS-PAGE followed by autoradiography. G␣ s -L and G␣ s -S indicate the long and short isoforms of G␣ s , respectively. A representative autoradiogram is shown; the experiment was repeated 3 times with similar results.
Stimulation of Histamine, Serotonin, and Glucagon Receptors in Human Atrial Membranes Also Activates G␣ i
In addition to ␤ARs, cardiac inotropy is also mediated through histamine, serotonin, and glucagon receptors. 20 Like ␤ARs, these receptors stimulate AC through G␣ s . Therefore, it was of interest to determine whether these receptors can also activate G␣ i . As shown in Figure 4 , G␣ i is strongly activated in the presence of histamine and glucagon and moderately activated in the presence of serotonin. Histamine, glucagon, and serotonin all significantly increase the incorporation of [ 32 P]AAGTP into G␣ i , to 189Ϯ16%, to 210Ϯ58%, and to 121Ϯ11% of control, respectively. A selective antagonist for each receptor can block the stimula-tion of G␣ i by that receptor, indicating that activation of G␣ i is a consequence of receptor stimulation (Figure 4 ).
Effect of PTX Treatment on AC Activity
The data of Figures 1 through 4 indicate that ␤ 2 AR and other G␣ s -coupled receptors couple to both G␣ s and G␣ i . Given that stimulation of G␣ i -coupled receptors inhibits AC, an obvious next question is whether the disruption of the coupling of these cardiac receptors to G␣ i removes this inhibitory component and increases receptor-mediated AC activation. Therefore, we treated human atrial membranes with PTX, which ADP-ribosylates G␣ i and disrupts its ability to interact with GPCRs. 21, 22 These data are shown in Figure 5 .
In control membranes, AC activity increases with stimulation of ␤ARs by isoproterenol to 254Ϯ46% of control. Selective activation of ␤ 1 ARs (by inclusion of both isoproterenol and the ␤ 2 AR antagonist ICI 118,551) stimulates AC to 178Ϯ27% of control, whereas selective activation of ␤ 2 ARs (by inclusion of both isoproterenol and the ␤ 1 AR antagonist CGP 20712A) stimulates AC to 140Ϯ22% of control. In addition, histamine and glucagon receptors stimulate AC to 145Ϯ31% and 156Ϯ48% of control, respectively; the stimulation of AC by serotonin (105Ϯ16% of control) was not statistically significant. Forskolin, a direct activator of AC, stimulates AC to 1104Ϯ326% of control. These data on AC stimulation in human atrium are similar to that reported by other investigators. 23, 24 In PTX-treated membranes, basal AC activity is significantly increased (to 442Ϯ266% of control), as is AC activity stimulated by agonists of various G␣ s -coupled receptors (␤ARs, 1091Ϯ676% of control; ␤ 1 ARs, 668Ϯ252%; ␤ 2 ARs, 907Ϯ393%; histamine receptors, 787Ϯ486%; glucagon receptors, 895Ϯ505%; and serotonin receptors, 852Ϯ448%) and by forskolin (1896Ϯ543% of control) ( Figure 5 ). Although PTX treatment increases AC activity under every condition tested, there is a greater increase in AC stimulation Figure 3 . Blockade of ␤ 2 AR, but not of ␤ 1 AR, abolishes isoproterenol-induced stimulation of G␣ i . Human atrial membranes were photoaffinity labeled with [ 32 P]AAGTP in the presence of no drug (Basal), isoproterenol (Iso), or Iso and either ICI 118,551 (ICI, ␤ 2 AR antagonist) or CGP 20712A (CGP, ␤ 1 AR antagonist), each drug at 100 mol/L, as described in Materials and Methods. The photolabeled membranes were immunoprecipitated with AS/7 antibody (for G␣ i ), and immunoprecipitates were subjected to SDS-PAGE followed by autoradiography. A representative autoradiogram is shown; the experiment was repeated 3 times with similar results. Figure 4 . Histamine, glucagon, and serotonin receptors couple to G␣ i . Human atrial membranes were photoaffinity labeled with [ 32 P]AAGTP in the presence of no drug (Basal) or various agonists, or agonists plus corresponding antagonists, as described in Materials and Methods. Agonists included were isoproterenol (Iso, 100 mol/L), histamine (Hist, 100 mol/L), glucagon (Gluc, 50 mol/L), and serotonin (5-HT, 100 mol/L). Antagonists included were ICI 118,551 (ICI) for ␤ 2 ARs, cimetidine (Cimet) for histamine receptors, des-His1-(Glu9)-glucagon (des-Gluc) for glucagon receptors, and SDZ-205,557 (SDZ) for serotonin receptors (all antagonist concentrations were the same as for the respective agonists). Photolabeled membranes were immunoprecipitated with AS/7 antibody (for G␣ i ), and immunoprecipitates were subjected to SDS-PAGE followed by autoradiography. A representative autoradiogram is shown; the experiment was repeated 3 times with similar results. through receptors that also couple to G␣ i . The PTX-induced increase in basal, forskolin-stimulated, and ␤ 1 AR-stimulated AC activities ranged from 1.7-to 4.4-fold, whereas the PTX-induced increase in AC activity after stimulation of receptors that couple to both G␣ s and G␣ i ranged from 5.4-to 8.1-fold, and the difference between the 2 groups is statistically significant (PϽ0.05). These results indicate that disruption of the coupling of G␣ s -coupled receptors to G␣ i enhances their ability to stimulate AC. Note that whereas stimulation of AC by serotonin in control membranes is not significant, it is highly significant in PTX-treated membranes.
Discussion
The main findings of this study are that, in human atrial membranes, (1) ␤ 2 AR activates both G␣ s and G␣ i ; (2) both G␣ s and G␣ i are also activated by several other receptors including glucagon, histamine, and serotonin; and (3) the coupling of these G␣ s -coupled receptors to G␣ i is functional, given that AC stimulation by these receptors is increased by PTX treatment. These findings add a new level of complexity into the signaling of human cardiac inotropic receptors.
The finding that ␤ 2 AR and other G␣ s -coupled receptors also couple to G␣ i is an important development. Initially, it was thought that G␣ s -coupled receptors and G␣ i -coupled receptors are activated by distinct hormones. For example, G␣ s -coupled ␤ARs are stimulated by the sympathetic hormones norepinephrine and epinephrine, and G␣ i -coupled muscarinic receptors are activated by the parasympathetic hormone acetylcholine. However, this apparently logical signaling scheme is complicated by the recent finding of Xiao et al 2 that cardiac ␤ 2 ARs also activate G␣ i . Specifically, they showed that PTX pretreatment in rat cardiac myocytes increases ␤ 2 AR-mediated responses, including increases in contraction amplitudes, calcium influx, and Ca i transients. Their finding has been supplemented by additional data showing potentiation of ␤ 2 AR functional responses by PTX as well as a direct labeling of G␣ i proteins due to ␤ 2 AR stimulation in rat and mouse cardiac myocytes. 3, 5, 25 In contrast, ␤ 1 AR responses are not sensitive to PTX, and direct photoaffinity labeling of mouse heart membranes did not detect any ␤ 1 AR-mediated G␣ i activation. 3 In the present study, we show that a similar situation occurs in human atrial tissue. More importantly, we find that G␣ i is also activated by stimulation of glucagon, histamine, and serotonin receptors. Thus, coupling to G␣ i is not a unique property of cardiac ␤ 2 ARs. In fact, with the exception of ␤ 1 ARs, coupling to both G␣ s and G␣ i appears to be a general property of cardiac G␣ s -coupled receptors in human atrial tissue.
Having demonstrated that ␤ 2 AR and several other G␣ scoupled receptors also activate G␣ i , we sought to determine whether disruption of G␣ i increases AC stimulation through G␣ s -coupled receptors. The data of Figure 5 show that disruption of G␣ i causes an increase in AC activity under every condition tested. An increase in basal and forskolinstimulated AC activity after PTX treatment implies that there exists a tonic inhibition of AC by G␣ i . This tonic inhibition of AC by G␣ i may also be responsible for the observed increase in ␤ 1 AR-stimulated AC activity after PTX treatment. Compared with the effect of PTX on AC stimulation through ␤ 1 ARs, which do not couple to G␣ i , the effect of PTX on AC stimulation through ␤ 2 ARs (and other G␣ s -coupled receptors that also couple to G␣ i ) is greater. These results indicate that coupling of G␣ s -coupled receptors to G␣ i has functional consequences at the level of AC. This conclusion, however, disagrees with similar studies in rat myocytes in which PTX treatment had no significant effect on ␤ 2 AR-mediated cAMP formation 26 or activation of protein kinase A. 25 On the basis of these data, Xiao et al 10 present a model depicting that the cross talk between the pathways stimulated by ␤ 2 AR coupling to G␣ s and G␣ i occurs at a point distal to AC and protein kinase A. Clearly, this rat model is not supported by our data with human atrial membranes.
The physiological function of the coupling of G␣ s -coupled receptors to G␣ i also remains to be fully evaluated. The ability of G␣ s -coupled receptors to also activate G␣ i raises the possibility that this pathway may become exaggerated when G␣ i levels are increased in both failing and aged hearts. Indeed, a decrease in ␤AR function in failing human heart and in the elderly has been observed. 27, 28 In addition to ␤ARs, histamine and serotonin receptors show decreased ability to stimulate AC in failing heart. 23 Whether this decrease in AC stimulation through G␣ s -coupled receptors in failing heart and aging is the result of an enhanced coupling to G␣ i remains to be determined. Interestingly, it was recently shown that activation of G␣ i by ␤ 2 AR stimulation opposes the apoptotic action of ␤ 1 AR stimulation in rat cardiac myocytes, and it was suggested that an increased activation of G i may be of therapeutic value. 29 In summary, the present study provides the first evidence that ␤ 2 ARs and several other GPCRs in human atrial tissue couple to both G␣ s and G␣ i ; disruption of the coupling of these receptors to G␣ i enhances their ability to stimulate AC.
